{"_id": "64ffe3e2748b29c10bbbeaea", "and": [{"$and": [{"prostate cancer histology": "adenocarcinoma"}, {"prostate cancer histology": {"$not": "small cell"}}]}, {"prostate cancer progression on androgen deprivation therapy": {"$lt": 180}}, {"metastatic disease": {"$or": [{"bone lesions": true}, {"soft tissue disease": true}]}}, {"abiraterone acetate exposure": {"$in": ["abiraterone-na\u00efve", "received prior abiraterone acetate for the treatment of mHSPC or mCRPC, for a minimum of 4 weeks and not progressed while on treatment", "received prior abiraterone acetate for the treatment of mHSPC or mCRPC and progressed on treatment after a minimum of 8 weeks treatment (minimum 14 weeks for those with bone progression)"]}}, {"androgen deprivation": {"$lt": 50}}, {"bone resorptive therapy": true}, {"$and": [{"refrain from donating sperm": true}, {"$or": [{"be abstinent": true}, {"must agree to use male condom": true}]}]}, {"biopsy sample": {"$or": [{"soft tissue biopsy": true}, {"bone biopsy": true}]}}, {"ECOG performance status": {"$in": [0, 1]}}], "$not": {"$or": [{"additional malignancy": true}, {"autoimmune disease": true}, {"immunodeficiency": true}, {"major surgery": true}, {"gastrointestinal disorder": true}, {"active infection": true}, {"pneumonitis/interstitial lung disease": true}, {"HIV infection": true}, {"CNS metastases": true}, {"hypersensitivity": true}, {"seizure history": true}, {"loss of consciousness history": true}, {"hypotension": true}, {"bradycardia": true}, {"ketoconazole treatment": true}, {"prior anti-PD-1/PD-L1/PD-L2 therapy": true}, {"prior radium or radiopharmaceutical treatment": true}, {"prior docetaxel or chemotherapy treatment": true}, {"prior anti-cancer monoclonal antibody therapy": true}, {"herbal product use": true}, {"live vaccine use": true}, {"participation in investigational study": true}, {"'superscan' bone scan": true}, {"expecting to conceive or father children": true}, {"allogenic tissue/solid organ transplant": true}]}}